OSI Systems Inc was originally incorporated in 1987 in California. In March 2010, it was reincorporated in the State of Delaware. The Company together with its subsidiaries is engaged in designing and manufacturing of specialized electronic systems and components for critical applications. Its business segments are Security, Healthcare, and Optoelectronics and Manufacturing. Through the Security division, the company provides security screening products and services under the "Rapiscan Systems" trade name. Rapiscan Systems products fall into the following categories: baggage and parcel inspection; cargo and vehicle inspection; hold (checked) baggage screening; people screening; radiation detection; and explosive and narcotics trace detection. Through Healthcare division, the company designs, manufactures, markets and services patient monitoring, diagnostic cardiology, anesthesia delivery and ventilation systems and defibrillators globally to end users under the "Spacelabs" and "Primedic" trade names, and related supplies and accessories under the names "Spacelabs" and "Statcorp Medical." Through the Optoelectronics and Manufacturing division, the company designs, manufactures and markets optoelectronic devices and provides electronics manufacturing services globally for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostics, telecommunications, office automation, computer peripherals, industrial automation systems, automotive diagnostic systems, gaming systems and consumer products. The Company market and sell security and inspection products and turnkey security screening solutions globally through a direct sales and marketing staff located in the Americas, Europe, Middle East, Africa, Asia and Australia, in addition to an expansive network of independent distributors. Its competitors include Smiths Detection, L‑3 Communications-Security and Detection Systems division, American Science and Engineering, Morpho Detection, Leidos, CEIA, Nuctech and Astrophysics, Philips Healthcare, GE Healthcare, Mindray Medical, Mortara Instrument, Dräger Medical, Nihon Kohden, Penlon, Maquet and Welch Allyn, Koninklijke Philips N.V., Zoll Medical Corporation, Physio-Control, Inc. and Cardiac Science. The Company is subject to U.S. Food and Drug Administration (FDA) and by other federal, state, local and foreign authorities.
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.